Development of a novel biomarker and treatment for major depressive disorder focusing on the ethanolamine in the cerebrospinal fluid
Development of a novel biomarker and treatment for major depressive disorder focusing on the ethanolamine in the cerebrospinal fluid
批准号:
16K19792
负责人:
OGAWA Shintaro
金额:
$2.5万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2016
资助国家:
日本
项目状态:
已结题
起止时间:
2016-04-01 至 2018-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Cerebrospinal Fluid Ethanolamine Concentration in Major Depressive Disorder: Relevance with Other Psychiatric Disorders and Clinical Features
重度抑郁症的脑脊液乙醇胺浓度:与其他精神疾病和临床特征的相关性
DOI:
--
发表时间:
2016
期刊:
影响因子:
--
作者:
[Shintaro Ogawa, Kotaro Hattori, Miho Ota, Hiroshi Kunugi]
通讯作者:
Hiroshi Kunugi
海外基金